SCHEMBL5739660

SCHEMBL5739660

O=C(Cl)c1ccc(NC(=O)c2ccccc2Cc2ccccc2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.49
▸ ADRB2 P07550 1/20 0.49
▸ BCL2 P10415 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PARP1 P09874 1/20 0.45
▸ SMO Q99835 1/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ BCAT2 O15382 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ FADS1 O60427 1/20 0.44
▸ DHODH Q02127 1/20 0.44
▸ KCNK3 O14649 1/20 0.44
▸ KCNK9 Q9NPC2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5235008 0.91 ALDH1A1 (0.50) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL5738843 0.87 MEN1 (0.49) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL5236516 0.82 ALDH1A1 (0.57) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL7334315 0.80 DHODH (0.68) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL27502192 0.80 ALDH1A1 (0.67) ALDH1A1ADRB2SMN1; SMN2KDM4ELMNA
SCHEMBL8971238 0.79 ALDH1A1 (0.73) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL27451969 0.79 ALDH1A1 (0.47) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL2960788 0.78 CHRNB2 (0.61) ALDH1A1KDM4ELMNASMOGAA
SCHEMBL27487499 0.76 LMNA (0.61) ALDH1A1ADRB2SMN1; SMN2KDM4ELMNA
SCHEMBL6581654 0.76 KDM4E (0.54) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804438-B1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS WYETH CORP (US) 2006-03-15 — — EP disclosed
CN-1065244-C Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID CO (US) 2001-05-02 — — CN disclosed
CN-1231666-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID CO (US) 1999-10-13 — — CN disclosed
EP-0915876-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS American Cyanamid Company (US) 1999-05-19 — — EP disclosed
WO-1997049708-A9 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS — 1998-05-22 — — WO disclosed
WO-1997049707-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-31 — — WO disclosed
WO-1997049708-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-31 — — WO disclosed
EP-0804438-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS American Cyanamid Company (US) 1997-11-05 — — EP disclosed
US-5612334-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1997-03-18 — — US disclosed
US-5610156-A USED IN TREATING DISEASES CHARACTERIZED BY EXCESS RENAL REABSORPTION OF WATER AMERICAN CYANAMID COMPANY (US) 1997-03-11 — — US disclosed
WO-1996022293-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 — — WO disclosed
US-5536718-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1996-07-16 — — US disclosed
Send feedback